Tempest Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2018 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Tempest Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2018 to Q4 2024.
  • Tempest Therapeutics, Inc. Depreciation for the quarter ending December 31, 2024 was $48K, a 43.5% decline year-over-year.
  • Tempest Therapeutics, Inc. Depreciation for the twelve months ending December 31, 2024 was $389K, a 2.1% increase year-over-year.
  • Tempest Therapeutics, Inc. annual Depreciation for 2024 was $389K, a 2.1% increase from 2023.
  • Tempest Therapeutics, Inc. annual Depreciation for 2023 was $381K, a 40.3% decline from 2022.
  • Tempest Therapeutics, Inc. annual Depreciation for 2022 was $638K, a 70.6% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $389K $48K -$37K -43.5% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-27
Q3 2024 $426K $98K +$10K +11.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $416K $155K +$72K +86.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $344K $88K -$37K -29.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $381K $85K -$132K -60.8% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-27
Q3 2023 $513K $88K -$113K -56.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $626K $83K -$29K -25.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $655K $125K +$17K +15.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $638K $217K +$114K +111% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 $524K $201K +$94K +87.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $430K $112K +$26K +30.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $404K $108K +$30K +38.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $374K $103K -$38K -27% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $412K $107K +$26K +32.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $386K $86K +$6K +7.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $380K $78K +$41K +111% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $339K $141K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 $81K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $80K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $37K +$29K +363% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 $8K +$2K +33.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q1 2018 $6K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.